• Applied Strategies for Asunaprevir (BMS-650032) in HCV Resea

  2026-05-28

  Asunaprevir (BMS-650032) delivers pan-genotypic precision for hepatitis C virus research, enabling robust NS3 protease inhibition across the most relevant cellular models. This guide cuts through complexity to provide actionable workflow enhancements, data-backed troubleshooting, and protocol optimization for translational virology and drug discovery teams.

• Practical Use of Methyl-β-cyclodextrin in Membrane Research

  2026-05-28

  Methyl-β-cyclodextrin enables researchers to selectively extract cholesterol and modulate membrane fluidity in cell membrane studies. This reagent is intended strictly for laboratory workflows investigating membrane dynamics or lipid raft organization, and is not suitable for diagnostic or medical use.

• 10058-F4: Enhancing c-Myc-Max Dimerization Inhibition Workfl

  2026-05-27

  10058-F4 stands out as a robust c-Myc-Max dimerization inhibitor, enabling precise modulation of oncogenic transcription and apoptosis in both leukemia and prostate cancer models. This article delivers actionable workflow guidance, advanced troubleshooting, and unique protocol enhancements to help researchers unlock the full translational potential of 10058-F4 in cancer and stem cell research.

• WY-14643 (Pirinixic Acid): PPARα Agonism and Tumor Microenvi

  2026-05-27

  Explore how WY-14643 (Pirinixic Acid) modulates PPARα activity, influencing both metabolic regulation and tumor microenvironment dynamics. This in-depth article uniquely analyzes recent multiomics insights and practical assay implications for advanced metabolic disorder research.

• Dabigatran (Pradaxa): Precision Tools for Coagulation Resear

  2026-05-26

  Dabigatran (Pradaxa) empowers researchers with unmatched selectivity and potency for thrombin inhibition assays, enabling translational breakthroughs in anticoagulation science. This article details practical experimental workflows, advanced use-cases, and actionable troubleshooting insights—anchored by recent clinical and bench evidence.

• SB743921: Precision Kinesin Spindle Protein Inhibitor Workfl

  2026-05-26

  Unlock reproducible mitotic arrest and apoptosis in cancer research with SB743921, a selective kinesin spindle protein inhibitor. This guide translates cutting-edge methodologies and troubleshooting insights into actionable protocols for advanced in vitro and xenograft studies.

• Applied Cyclosporin A Workflows: Immunosuppression to Viral

  2026-05-25

  Cyclosporin A, a benchmark cyclophilin inhibitor, enables precise immunosuppression, cell survival modulation, and advanced viral entry studies. This guide translates core mechanisms and breakthrough delivery innovations into actionable workflows, with troubleshooting insights and protocol enhancements for reproducible research.

• Forskolin as a Cross-Domain Tool: From cAMP Modulation to Hu

  2026-05-25

  Explore how Forskolin, a potent adenylate cyclase activator, enables advanced cAMP signaling assays and uniquely bridges cardiovascular, stem cell, and neuronal HSV-1 research. This article reveals Forskolin’s cross-domain utility, referencing the latest human sensory neuron model breakthroughs.

• Amyloid β-Peptide (1-42): Protocol Innovations & Troubleshoo

  2026-05-24

  Unlock robust Alzheimer's disease research using Amyloid β-Peptide (1-42) (Aβ42) with optimized protocols and actionable troubleshooting tips. Leverage recent advances in microglial phagocytosis and ion channel assays for reproducible, translational neuroscience workflows.

• (+)-Bicuculline: Technical Guide for GABAA Antagonist Applic

  2026-05-23

  (+)-Bicuculline is a classical GABAA receptor antagonist used to dissect inhibitory neurotransmission and modulate synaptic NMDA receptor signaling in neuroscience research. It should be employed under rigorous solubility and storage protocols, and is not suitable for diagnostic or clinical use. Researchers should follow well-defined workflow best practices to ensure experimental reliability.

• LNP-Delivered NGFR100W mRNA: A Novel Strategy for Neuropathy

  2026-05-22

  The referenced study demonstrates that lipid nanoparticle (LNP) delivery of chemically modified NGFR100W mRNA enables potent, 'painless' neuroprotective activity in models of peripheral neuropathy. This approach addresses key challenges in therapeutic protein delivery and provides molecular insights relevant for mRNA stability, immunogenicity, and functional validation.

• Targeting SWI/SNF ATPases in H3K27M Pediatric Gliomas: Mecha

  2026-05-22

  This article examines the pivotal discovery that H3.3K27M mutant diffuse intrinsic pontine gliomas (DIPGs) depend on SWI/SNF ATPase subunits for survival, and that their combined degradation selectively induces cytotoxicity in mutant cells. The study provides a mechanistic rationale for targeting chromatin remodeling complexes in pediatric brain cancers, with implications for advancing therapeutic strategies and refining phosphoproteomic workflows.

• PAK1 Inhibition Accelerates mRNA Decay and Synergizes with O

  2026-05-21

  This study demonstrates that targeting PAK1 in colorectal cancer enhances the decay of oncogenic mRNAs and significantly improves the efficacy of platinum-based chemotherapeutic agents like Oxaliplatin. These findings present a mechanistic rationale for combining PAK1 inhibitors with established chemotherapy regimens to suppress tumor progression.

• Luminescent ATP Cell Viability Assay Kit I: Benchmarking Sen

  2026-05-21

  Harness the ultra-sensitive luciferase luminescence detection of the Luminescent ATP Cell Viability Assay Kit I to accelerate cell viability measurement and cytotoxicity workflows. Discover how robust protocol design, troubleshooting, and insights from p21-ELP peptide research drive reproducibility and precision in advanced cell biology studies.

• Norovirus Utilizes NINJ1 for Selective Viral Protein Secreti

  2026-05-20

  Song et al. reveal that murine norovirus hijacks the host protein NINJ1 to enable selective secretion of the viral NS1 protein, a process dependent on caspase-3-mediated cleavage. This work uncovers a new paradigm in how viruses exploit programmed cell death machinery for immune evasion and protein export.

11494 records 1/767 page Next 12345 下5页 Last page